PTCT FY 2019 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$5B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$307M+16.0% YoY

Gross Profit

$295M96.0% margin

Operating Income

-$241M-78.6% margin

Net Income

-$252M-82.0% margin

EPS (Diluted)

$-4.27

Cash Flow

Operating Cash Flow

-$99M

Free Cash Flow

-$144M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$1.0B

Stockholders' Equity

$594M

Cash & Equivalents

$288M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$307M	$265M	+16.0%
Gross Profit	$295M	$252M	+17.0%
Operating Income	-$241M	-$116M	-108.5%
Net Income	-$252M	-$128M	-96.4%